Proteomic Analyses Associate Cystatin B with Restricted HIV-1 Replication in Placental Macrophages

Placenta

Volumn 29, Issue 12, 2008, Pages 1016-1023

  Luciano Montalvo, C ^a   Ciborowski, P ^b   Duan, F ^b   Gendelman, H E ^b   Melendez L M ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cystatin B; HIV; MDM; Placental macrophages; siRNA; SOD

Indexed keywords

CYSTATIN B; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIQUID CHROMATOGRAPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VIROGENESIS; VIRUS REPLICATION; WESTERN BLOTTING;

CELLS, CULTURED; CYSTATIN B; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MACROPHAGES, PERITONEAL; PHAGOCYTES; PLACENTA; PREGNANCY; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VIRUS REPLICATION;

EID: 56249108747     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.09.005     Document Type: Article

References (29)

1. Meltzer M.S., and Gendelman H.E. Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. Curr Top Microbiol Immunol 181 (1992) 239-263
2. McGann K.A., Collman R., Kolson D.L., Gonzalez-Scarano F., Coukos G., Coutifaris C., et al. Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis 169 (1994) 746-753
3. Menu E., Mbopi-Keou F.X., Lagaye S., Pissard S., Mauclere P., Scarlatti G., et al. Selection of maternal human immunodeficiency virus type 1 variants in human placenta. European Network for In Utero Transmission of HIV-1. J Infect Dis 179 (1999) 44-51
4. Patterson B.K., Tjernlund A., and Andersson J. Endogenous inhibitors of HIV: potent anti-HIV activity of leukemia inhibitory factor. Curr Mol Med 2 (2002) 713-722
5. Kesson A.M., Fear W.R., Kazazi F., Mathijs J.M., Chang J., King N.J., et al. Human immunodeficiency virus type 1 infection of human placental macrophages in vitro. J Infect Dis 168 (1993) 571-579
6. Melendez-Guerrero LM. In vitro infection of Hofbauer cells with a monocyte-tropic strain of HIV-1. University of Rochester Press, New York; 1994.
7. Plaud-Valentin M., Delgado R., Garcia V., Zorrilla C., Gandia J., and Melendez-Guerrero L.M. HIV infection of placental macrophages: effect on the secretion of HIV stimulatory cytokines. Cell Mol Biol (Noisy-le-grand) 45 (1999) 423-431
8. Melendez J., Garcia V., Sanchez E., Delgado R., Torres G., and Melendez-Guerrero L.M. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?. Cell Mol Biol (Noisy-le-grand) 47 (2001) Online Pub, OL51-9
9. Torres G., Garcia V., Sanchez E., Segarra A., Patterson B.K., and Melendez-Guerrero L.M. Expression of the HIV-1 co-receptors CCR5 and CXCR4 on placental macrophages and the effect of IL-10 on their expression. Placenta 22 Suppl. A (2001) S29-S33
10. Patterson B.K., Behbahani H., Kabat W.J., Sullivan Y., O'Gorman M.R., Landay A., et al. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest 107 (2001) 287-294
11. Lunardi-Iskandar Y., Bryant J.L., Blattner W.A., Hung C.L., Flamand L., Gill P., et al. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nat Med 4 (1998) 428-434
12. Polliotti B.M., Gnall-Sazenski S., Laughlin T.S., and Miller R.K. Inhibitory effects of human chorionic gonadotropin (hCG) preparations on HIV infection of human placenta in vitro. Placenta 23 Suppl. A (2002) S102-S106
13. Bourinbaiar A.S., and Nagorny R. Inhibitory effect of human chorionic gonadotropin (hCG) on HIV-1 transmission from lymphocytes to trophoblasts. FEBS Lett 309 (1992) 82-84
14. Ciborowski P., Kadiu I., Rozek W., Smith L., Bernhardt K., Fladseth M., et al. Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome. Virology 363 (2007) 198-209
15. Gendelman H.E., Orenstein J.M., Martin M.A., Ferrua C., Mitra R., Phipps T., et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 167 (1988) 1428-1441
16. Laspiur J.P., Anderson E.R., Ciborowski P., Wojna V., Rozek W., Duan F., et al. CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol 192 (2007) 157-170
17. Gimenez-Barcons M., Clotet B., and Martinez M.A. Endoribonuclease-prepared short interfering RNAs induce effective and specific inhibition of human immunodeficiency virus type 1 replication. J Virol 81 (2007) 10680-10686
18. Beyer S., Walter Y., Hellmann J., Kramer P.J., Kopp-Schneider A., Kroeger M., et al. Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF-MS spectra. J Proteome Res 5 (2006) 254-261
19. Storey J.D., Taylor J.E., and Siegmund D. Strong control, conservative point estimation, and simultaneous conservative consistency of false discovery rate: a unified approach. J R Stat Soc Series B 66 (2004) 187-205
20. Zielske S.P., and Stevenson M. Modest but reproducible inhibition of human immunodeficiency virus type 1 infection in macrophages following LEDGFp75 silencing. J Virol 80 (2006) 7275-7280
21. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess Jr. J.W., et al. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol 80 (2006) 9039-9052
22. Kadiu I., Ricardo-Dukelow M., Ciborowski P., and Gendelman H.E. Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells. J Immunol 178 (2007) 6404-6415
23. Ryckman C., Robichaud G.A., Roy J., Cantin R., Tremblay M.J., and Tessier P.A. HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4 + T lymphocytes. J Immunol 169 (2002) 3307-3313
24. Mazzocco M., Maffei M., Egeo A., Vergano A., Arrigo P., Di Lisi R., et al. The identification of a novel human homologue of the SH3 binding glutamic acid-rich (SH3BGR) gene establishes a new family of highly conserved small proteins related to thioredoxin superfamily. Gene 291 (2002) 233-239
25. Geiben-Lynn R., Kursar M., Brown N.V., Addo M.M., Shau H., Lieberman J., et al. HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. J Biol Chem 278 (2003) 1569-1574
26. Nakanishi T., Ozaki Y., Blomgren K., Tateyama H., Sugiura-Ogasawara M., and Suzumori K. Role of cathepsins and cystatins in patients with recurrent miscarriage. Mol Hum Reprod 11 (2005) 351-355
27. Divya, Chhikara P., Mahajan V.S., Datta Gupta S., and Chauhan S.S. Differential activity of cathepsin L in human placenta at two different stages of gestation. Placenta 23 (2002) 59-64
28. Varanou A., Withington S.L., Lakasing L., Williamson C., Burton G.J., and Hemberger M. The importance of cysteine cathepsin proteases for placental development. J Mol Med 84 (2006) 305-317
29. Afonso S., Romagnano L., and Babiarz B. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation. Development 124 (1997) 3415-3425